Metraipolis › archive › dc_ef6b400dbb8f

Pharmacogenomic impact and genetic architecture of toxicity in pediatric acute lymphoblastic leukemia induction therapy: an exploratory modeling approach — Europe PMC PMID:42382175

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382175
DOI
10.3389/fphar.2026.1830183
License (as archived)
solo-consultazione
Archived
2026-10-08T03:26:28.382Z
SHA-256 of the archived text
b4e7fb10e5c92fe2169e766adfc84d0950cfe9f62b0cbe6708c2b02af16b369e
Stable URL of this page
https://metraipolis.com/documento/dc_ef6b400dbb8f

How to cite

Pharmacogenomic impact and genetic architecture of toxicity in pediatric acute lymphoblastic leukemia induction therapy: an exploratory modeling approach — Europe PMC PMID:42382175 — Europe PMC (en), https://europepmc.org/article/MED/42382175 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef6b400dbb8f (Metraipolis archive dc_ef6b400dbb8f, sha256 b4e7fb10e5c92fe2169e766adfc84d0950cfe9f62b0cbe6708c2b02af16b369e)
BibTeX
@misc{dcef6b400dbb8f,
  title = {Pharmacogenomic impact and genetic architecture of toxicity in pediatric acute lymphoblastic leukemia induction therapy: an exploratory modeling approach — Europe PMC PMID:42382175},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382175},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef6b400dbb8f; sha256 b4e7fb10e5c92fe2169e766adfc84d0950cfe9f62b0cbe6708c2b02af16b369e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382175. Agents can read the archived copy with the MCP tool read_document.